Peter Bryan

Peter Bryan: Email & Phone Number

Opt-Out
Clinical Pharmacology, Bioanalytical Subject Matter Expert at Fulcrum Therapeutics|Mendham, New Jersey, United States

Position:

Clinical Pharmacology, Bioanalytical Subject Matter Expert at Fulcrum Therapeutics

Location:

Mendham, New Jersey, United States

LinkedIn
View Peter Bryan's Email
Up to 10 free lookups. No credit card required.
Last updated: 2025-10-23
Updated: 2025-10-23

Found email addresses for Peter Bryan:

Business emails:

Found phone for Peter Bryan:

Searching for Peter Bryan profiles
0% completed

A different Peter Bryan?

Sign up to search for other Peter Bryan's across our 850M+ professionals database

Work Experience 25 years

Clinical Pharmacology, Bioanalytical Subject Matter Expert at Fulcrum Therapeutics

Jun 2023 - Current

Industry Consultant and Subject Matter Expert at B2S Life Sciences (B2S Consulting)

Jun 2013 - Jun 2023

Associate Director (Senior Principal Scientist) - DMPK at Celgene

Oct 2006 - Nov 2012

Manager - Bioanalytical and Drug Metabolism Department at Forest Laboratories (now Allergan)

May 2001 - Oct 2006

Peter Bryan started working in 2001, then the employee has changed 3 companies and 3 jobs. On average, Peter Bryan works for one company for 6 years 1 month.

Their professional focus is 21 CFR Part 11, Analytical Chemistry, and Bioanalysis across 3 core areas.

Education

Ph.D. at The University of Georgia

Bachelor’s Degree at Samford University

Bachelor of Science (B.S.) at The University of the South

Frequently Asked Questions

What is Peter Bryan's email address?

SignalHire found a verified business email address for Peter Bryan: p*********n@fulcrumtx.com.

What is Peter Bryan's phone number?

SignalHire found a verified phone number for Peter Bryan: +1-***-***-5472.

How do I contact Peter Bryan at Fulcrum Therapeutics?

You can reach Peter Bryan through SignalHire by unlocking their verified email and direct phone number (free signup, no credit card needed). SignalHire is the fastest route if you need their contact details immediately.

What is Peter Bryan's professional background?

Peter Bryan has 25 years of professional experience. They have held roles including Industry Consultant and Subject Matter Expert, Associate Director (Senior Principal Scientist) - DMPK, and Manager - Bioanalytical and Drug Metabolism Department at companies such as B2S Life Sciences (B2S Consulting), Celgene, and Forest Laboratories (now Allergan). Their education includes Ph.D. from The University of Georgia, and Bachelor’s Degree from Samford University.

Is Peter Bryan's contact information up to date?

Yes. Peter Bryan's SignalHire profile was last updated on 23 October 2025, reflecting their current position as Clinical Pharmacology, Bioanalytical Subject Matter Expert at Fulcrum Therapeutics in Cambridge, Massachusetts, United States.

Peter Bryan Namesakes

Name
Company
Position
Peter Bryan
Director, Platforms and Technology
Get contacts
Peter Bryan
Partner
Get contacts
Peter Bryan
Bryan and Associates
Interim Fire Chief and Fire Protection Consultant
Get contacts
See more profiles

Other employees at Fulcrum Therapeutics

Name
Company
Position
Kim Hazen
Vice President, Human Resources
Get contacts
Alan Musso
Chief Financial Officer
Get contacts
Christy Copeland
Senior Director Medical Affairs
Get contacts
Josh Lehrer
Board Member
Get contacts
Anil Raghani
Senior Director, Analytical Chemistry, QC/CMC Development
Get contacts
Alex Sapir
Chief Executive Officer
Get contacts
Joseph Maglio
Associate Scientist
Get contacts
Robert Gould
President and C.E.O.
Get contacts
See more profiles

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP